Gus Alva
- Psychiatry and Mental health top 5%
- Neurology top 10%
- Cognitive Neuroscience
- Pharmacology top 10%
- Cellular and Molecular Neuroscience
- Co-authors
- Steven G. PotkinD. CarreonJames L. KennedyYi JinVincenzo S. BasileMario MasellisXiangyi MengW.E. Bunney
- Topics
- Schizophrenia research and treatment (5 papers)Parkinson's Disease Mechanisms and Treatments (3 papers)Tryptophan and brain disorders (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Gus Alva
12 papers receiving 413 citations
Peers
Comparison fields: 5 of 61
- Psychiatry and Mental health 227
- Neurology 91
- Cognitive Neuroscience 87
- Pharmacology 79
- Cellular and Molecular Neuroscience 69
Countries citing papers authored by Gus Alva
This map shows the geographic impact of Gus Alva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gus Alva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gus Alva more than expected).
Fields of papers citing papers by Gus Alva
This network shows the impact of papers produced by Gus Alva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gus Alva. The network helps show where Gus Alva may publish in the future.
Co-authorship network of co-authors of Gus Alva
This figure shows the co-authorship network connecting the top 25 collaborators of Gus Alva. A scholar is included among the top collaborators of Gus Alva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gus Alva. Gus Alva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 15 | |
| 3 | 16 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 46 | |
| 7 | 14 | |
| 8 | 99 | |
| 9 | 84 | |
| 10 | Predicting Clinical Antipsychotic Doses from Preclinical and PET studies: A Case Study with Asenapine | 1 |
| 11 | 2 | |
| 12 | 131 |
About Gus Alva
Gus Alva is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Neurology, having authored 12 papers that have together received 424 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Psychiatry and Mental health (227 citations), Biological Psychiatry (31 citations) and Neurology (91 citations). Gus Alva has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Steven G. Potkin, D. Carreon, James L. Kennedy, Yi Jin, Vincenzo S. Basile, Mario Masellis, Xiangyi Meng, W.E. Bunney, Fabìo Macciardi and W. Kalow. Their work appears in journals such as Molecular Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.